Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
FEBS Letters|August 16, 2024
Crystal structure and enzyme engineering of the broad substrate spectrum l-amino acid oxidase 4 from the fungus Hebeloma cylindrosporumSimon Koopmeiners, Dominic Gilzer, Christiane Widmann, et al.
Gender Medicine|November 18, 2011
Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?Annemarie Unger, Reinhold Jagsch, Andjela Bäwert, et al.
European Addiction Research|May 8, 2009
Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatmentBernadette Winklbaur, Andjela Baewert, Reinhold Jagsch, et al.
Chembiochem : a European Journal of Chemical Biology|June 27, 2023
Co-Immobilization of a Multi-Enzyme Cascade: (S)-Selective Amine Transaminases, l-Amino Acid Oxidase and CatalaseTobias Heinks, Simon Koopmeiners, Nicolai Montua, et al.
Drug and Alcohol Review|November 3, 2020
The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivitySuky Martinez, Jermaine D Jones, Nehal P Vadhan, et al.
Substance Abuse|August 20, 2020
Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorderJermaine D Jones, Aimee N Campbell, Laura Brandt, et al.
Frontiers in Cell and Developmental Biology|September 16, 2022
The SNARE protein Vti1b is recruited to the sites of BCR activation but is redundant for antigen internalisation, processing and presentationAmna Music, Blanca Tejeda-González, Diogo M Cunha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Epsin N-terminal homology domains bind on opposite sides of two SNAREsJing Wang, Michael Gossing, Pengfei Fang, et al.
Human Psychopharmacology|November 20, 2012
Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent womenBernadette Winklbaur-Hausknost, Reinhold Jagsch, Klaudia Graf-Rohrmeister, et al.
BMC Research Notes|July 1, 2011
Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trialAndreas Maieron, Sigrid Metz-Gercek, Thomas-Matthias Scherzer, et al.
Pageof 16